About Us
Global leader in separation system manufacturing
CARR Biosystems About Us

History


The CARR Biosystems Story


CARR Separations was founded in 1993 by Robert “Bret” Carr and his father Bob Carr in Medfield, MA. Together, they introduced the Powerfuge Separation System, the first high-speed, solid bowl centrifuge with automatic solids discharge. Through the 1990's, CARR Separation established itself as an industry innovator and a world-class supplier of liquid-solid separation to the Life Sciences and Specialty Chemical markets.
In 2000, CARR Separations was acquired by Kendro Laboratories Products LLC. The Powerfuge and Viafuge Separation Systems were combined with Centritech Separation Systems to form the Kendro Bioprocess division.
In 2004, Barry-Wehmiller (Pneumatic Scale Angelus) acquired CARR Centritech Separation Systems, relocating all functions to Clearwater, Florida. In 2009, the company introduced the UniFuge® Single-Use Separation System.

our_story

In 2022, CARR Centritech became CARR Biosystems. Today, CARR Biosystems draws on our decades of expertise with a renewed focus on high-quality centrifugal separation systems. Our high-quality products are designed to meet the most stringent safety and quality standards across multiple applications.

 

See What Sets Us Apart

The CARR Biosystems Edge

Pioneering High-Performance

Focusing on centrifugation for over 25 years gave us the unmatched expertise to pioneer single-use centrifuge solutions. Top biopharmaceutical and other leading companies worldwide confidently use our equipment to help produce high-quality biological medicines and other products.

scalability-image
Scalable

We have the only portfolio that covers single-use bioprocessing needs from early-stage development to commercial scale manufacturing.

versatile-image
Versatile

Our best-in-class high-performance systems are transforming the bioseparation market across applications in segments from cell therapy, gene therapy, monoclonal antibodies, recombinant proteins, to vaccines, and more.

human-care-image
Fundamentally Human

Caring for people is our primary core value. This extends from how we conduct our business, to how we support our customers in bringing life-changing and life-enhancing solutions to the market.

Leadership


Meet Our Team

 

Joel Williams
President

As President of CARR Biosystems, Joel Williams is responsible for driving the transformational growth agenda. Embracing the values and leadership style of the broader Barry-Wehmiller organization, he joined CARR in 2022 to build upon the growing commercial momentum of the innovative centrifuge business.


Prior to joining CARR, Joel served as the President, Pharmaceutical and Advanced Technology Business Group for ILC Dover, a leader in single-use technologies for biotherapeutic and pharma applications. Prior to ILC Dover, Joel led life sciences businesses at Avantor and Smiths Medical.


In his career, Joel has held various leadership positions in business management, sales, marketing, strategy, operations, finance, and technology development at companies including Intel, Dow Chemical, Bray International, and a Google-funded startup. Having worked and lived on three continents during that time, he brings a global perspective to CARR Biosystems.


Joel holds a Bachelor of Science degree in Mechanical Engineering from Brigham Young University, a Master of Science degree in Materials Science from the Massachusetts Institute of Technology, and a Master of Business Administration degree from Harvard Business School.


Mike Welch
Director of Sales

As Director of Sales for CARR Biosystems, Mike is responsible for leading the sales organization of Barry-Wehmiller’s growing centrifuge business.


Mike became the first commercial team member of CARR Separations in 1994, which was renamed CARR Biosystems in 2022. He is the originator and thought leader for the UniFuge single-use centrifuge, which was developed for the life sciences industry. Mike brings more than 35 years of life sciences experience to CARR, having developed new markets in microbial fermentation, vaccines, cell therapy, gene therapy, monoclonal antibodies, and cellular agriculture during that time.


Mike holds a Bachelor of Arts degree in Economics from
Providence College.

raymond-colton
Raymond (Ray) Colton
VP of Operations

As VP of Operations for CARR Biosystems, Ray is directly responsible for planning, project management, engineering, assembly and fulfilment of customer orders. He has local operational responsibility for procurement, quality, customer service and sales support. Prior to this role, Ray served as the Director of Quality Assurance for CARR.


Prior to joining CARR, Ray founded VR Analytical, a cGMP testing laboratory, which became a leading provider of extractables and leachables testing for the biopharmaceutical industry. Most recently, he has served as a consultant for choice of materials used in FDA regulated industries including extractables, leachables, and chemical compatibility.


Ray holds a Master of Science degree in Chemical Engineering from University of Washington and a Master of Business Administration degree from New York University.


Careers
Work With Us
Interested in a career with CARR® Biosystems? We strive to offer every team member meaningful work in an environment of care, compassion and human connection. Take a look at our current job openings using the link below.
Learn more
work_with_us
about-us-round
Stay Connected
Contact Us
Get in touch with a sales representative, request support or download our free white paper.
Contact Us